| Name: | Apixaban 4,5-Dehydro Carboxamide |
| Catalogue No. | VL3170014 |
| CAS No. | 1074549-89-5 |
| Molecular Formula | C25H23N5O4 |
| Molecular Weight | 457.48 |
| Status | In-stock |
| IUPAC Name | 6,7-Dihydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl) phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
| Description | Apixaban 4,5-Dehydro Carboxamide (CAS No: N/A) or sodium (2S,3S,4S,5R,6S)-6-(4-((R)-1-(4-acetamido-1,3-dioxoisoindolin-2-yl)-2-(methylsulfonyl)ethyl)-2-ethoxyphenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylat, it produces its antithrombotic effect by inhibiting free and clot-bound factor Xa and is used as Treatment And Prevention of Thromboembolic Disease. |
| References | Budovich, Aliaksandr, et al. “Role of Apixaban (Eliquis) in the Treatment and Prevention of Thromboembolic Disease.” Pharmacy and Therapeutics, vol. 38, no. 4, 1 Apr. 2013, pp. 206–231, www.ncbi.nlm.nih.gov/pmc/articles/PMC3684191/#b5-ptj3804206. Accessed 24 Jan. 2022. |
